Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

[Ceftaroline, a new broad-spectrum cephalosporin in the era of multiresistance]

Juan Pablo Horcajada1, Rafael Cantón2

  • 1Servicio de Enfermedades Infecciosas, Hospital Universitario del Mar, Institut Hospital del Mar d'Investigació Mèdica (IMIM), Barcelona, España.

Enfermedades Infecciosas Y Microbiologia Clinica
|April 8, 2014
PubMed

Insights

Antimicrobial resistance is a growing public health threat. Ceftaroline, a novel cephalosporin, offers a new treatment option for infections caused by resistant bacteria like MRSA.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Rising antimicrobial resistance poses a significant public health challenge.
  • Methicillin-resistant Staphylococcus aureus (MRSA) and resistant Streptococcus pneumoniae are key concerns.
  • Existing treatments are limited against these multidrug-resistant pathogens.

Purpose:

  • To review the efficacy and potential expanded indications of ceftaroline.
  • To highlight ceftaroline's role as a first-line β-lactam antibiotic against MRSA.
  • To assess ceftaroline's microbiological and pharmacokinetic/pharmacodynamic (PK/PD) profiles.

Summary:

  • Ceftaroline is a broad-spectrum cephalosporin effective against MRSA and penicillin-resistant S. pneumoniae.
  • Phase-III trials confirm its efficacy in community-acquired pneumonia and skin/soft tissue infections.
  • Its PK/PD profile suggests potential for treating bacteremia, endocarditis, and osteoarticular infections.

Impact:

  • Ceftaroline provides a crucial therapeutic option for infections caused by resistant Gram-positive bacteria.
  • Its activity against certain Gram-negative pathogens broadens its utility in polymicrobial infections.
  • Further clinical data will refine ceftaroline's indications and optimize its use in combating antimicrobial resistance.
Keywords:
CeftarolinaCeftarolineMRSAMultiresistantMultirresistenteNew antimicrobialsNuevos antimicrobianosSARMStreptococcus pneumoniae

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

29.0K
Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

11.1K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K